Natural anti-immunoglobulin autoantibodies: Irrelevant by-products or immunoregulatory molecules?

International Archives of Allergy and Immunology

Volumn 115, Issue 4, 1998, Pages 270-277

  Terness, P ^a   Opelz, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anti IgG antibody; Autoantibodies; IgG; Immunosuppression; Natural antibodies; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY COMBINING SITE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; IMMUNOGLOBULIN GENE; IMMUNOREGULATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; B-LYMPHOCYTES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS;

EID: 0031912990     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069457     Document Type: Review

References (86)

1. Johnson PM, Faulk WP: Rheumatoid factor: Its nature, specificity, and production in rheumatoid arthritis. Clin Immunol Immunopathol 1976;6:414-430.
2. Shakib F: Autoantibodies to immunoglobulins. Monogr Allergy, Basel, Karger, 1989, vol 26, pp 1-270.
3. Kallerup HE, Egeskjold EM, Graudal H: IgG-, IgM-, and IgA-rheumatoid factors in healthy adults and rheumatoid patients determined by an indirect immunofluorescence method. Scand J Rheumatol 1979;8:1-9.
4. Chatpar PC, Muller D, Gruber B, Kaplan AP, Gorevic PD: Prevalence of IgE rheumatoid factor (IgE RF) in mixed cryoglobulinemia and rheumatoid arthritis. Clin Exp Rheumatol 1986; 4:313-317.
5. Poljak R: An idiotope-anti-idiotope complex and the structural basis of molecular mimicking. Proc Natl Acad Sci USA 1992;89:6770-6771.
6. Moore TL, Dorner RW: Rheumatoid factors. Clin Biochem 1993;26:75-84.
7. Jefferis R: Rheumatoid factors, B cells and immunoglobulin genes. Br Med Bull 1995;51: 312-331.
8. Milgrom F, Witebsky E: Studies on the rheumatoid and related serum factors. I. Autoimmunizalion of rabbits with gamma globulin. JAMA 1960;174:138-145.
9. Aho K, Wager O: Production of 'anti-antibodies' in rabbits. Appearance in rabbit serum of 'anti-antibodies' reacting with autogenous and isogenous antibody, following autostimulation with protein antigens. Ann Med Exp Fenn 1961; 39:79-87.
10. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-1215.
11. Dresser DW: Most IgM-producing cells in the mouse secrete auto-antibodies (rheumatoid factor). Nature 1978;274:480-483.
12. Dresser DW, Popham AM: Rheumatoid factors in mice: Plaque assay for homophile and heterophile rheumatoid factors. Immunology 1980; 41:569-577.
13. Coulie P, van Snick J: Rheumatoid factors and secondary immune responses in the mouse. II. Incidence, kinetics, and induction mechanisms. Eur J Immunol 1983;13:895-899.
14. Van Snick J, Coulie P: Rheumatoid factors and secondary immune responses in the mouse. I. Frequent occurrence of hybridomas secreting IgM anti-IgG1 autoantibodies after immunization with protein antigens. Eur J Immunol 1983; 13:890-894.
15. Nemazee DA, Sato VL: Induction of rheumatoid antibodies in the mouse. Regulated production of autoantibody in the secondary humoral response. J Exp Med 1983;158:529-545.
16. Nemazee DA, Sato VL: Enhancing antibody: A novel component of the immune response. Proc Natl Acad Sci USA 1982;79:3828-3832.
17. Brown EJ, Bekisz J: Neoantigens appear in human IgG upon antigen binding: Detection by antibodies that react specifically with antigen-bound IgG. J Immunol 1984;132:1346-1352.
18. Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Lanchance JG, Largiader F, Lange H, Vujaklija-Stipanovic K, Alvarez-Grande J, Schott W, Hoyer J, Schnuelle P, Descoeudres C, Ruder H, Wujciak T, Schwarz V: Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997;63:964-967.
19. Terness P, Schiffl R, Süsal C, Opelz G: Induction of a suppressive serum factor, prevention of sensitization, and prolongation of kidney graft survival in rats by transfusion with antibody-coated blood cells. Transplantation 1988;46: 812-819.
20. Terness P, Schiffl R, Süsal C, Guo Z, Opelz G: Long-lasting kidney graft survival after immunization with antibody-coated blood cells: Mediation by immunosuppressive autoantibodies. Immunol Lett 1990;26:139-144.
21. Rose HM, Ragan C, Pearce E, Lipman MO: Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 1948;68:1-12.
22. Carson DA, Chen PP, Fox RI, Kipps TJ, Jink F, Goldfien RD, Silverman G, Radoux V, Fong S: Rheumatoid factor and immune networks. Annur Rev Immunol 1987;5:109-126.
23. Levo Y, Gorevic PP, Kassab HJ, Zucker-Franklin D, Franklin EC: Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977;296:1501-1504.
24. Carson DA, Bayer AS, Eisenberg RA, Lawrence S, Theofilopoulos A: IgG rheumatoid factor in subacute bacterial endocarditis: Relationship to IgM rheumatoid factor and circulating immune complexes. Clin Exp Immunol 1978; 31:100-103.
25. Terness P, Süsal C, Baur C, Guo Z, Opelz G: A B-cell-suppressive IgG-anti-immunoglobulin antibody induced by alloimmunization. Transplantation 1990;50:502-505.
26. 2 antibodies by buffy coat transfusions and their effect in kidney transplantation. Transplant Proc 1990; 22:1893-1894.
27. Welch MJ, Fong S, Vaughan J, Carson D: Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol 1983;51:299-304.
28. Birdsall HH, Rossen RD: Characterization of anti-Fab antibodies in human sera: Identification of soluble immune complexes that contain hidden anti-KHL and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin. Clin Exp Immunol 1983; 53:497-504.
29. Birdsall HH, Rossen RD: Regulation of antibody release by naturally occurring anti-immunoglobulins in cultures of pokeweed mitogen-stimulated human peripheral blood lymphocytes. J Immunol 1984;133:1257-1264.
30. Koopman WJ, Schrohenloher RE: In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults. J Immunol 1980;125: 934-939.
31. 2 portion of IgG. Clin Exp Immunol 1980; 42:378-386.
32. Jefferis R, Mageed RA: The specificity and reactivity of rheumatoid factors with human IgG. Monogr Allergy 1989;26:45-60.
33. Artandi SE, Canfield SM, Tao MH, Calame KL, Morrison SL, Bonagura VR: Molecular analysis of IgM rheumatoid factor binding to chimeric IgG. J Immunol 1991;146:603-610.
34. Allen JC, Kunkel HG: Hidden rheumatoid factors with specificity for native gamma globulins. Arthritis Rheum 1966;9:758-768.
35. Bonagura VR, Artandi SE, Davidson A, Randen I, Agostino N, Thompson K, Natvig JB, Morrison SL: Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors. J Immunol 1993;151:3840-3852.
36. Artandi SE, Calame KL, Morrison SL, Bonagura VR: Monoclonal IgM rheumatoid factors bind to a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3. Proc Null Acad Sci USA 1992;89:94-98.
37. Mageed RA, Carson DA, Jefferis R: Immunogenic and antigenic epitopes of immunoglobulins. XXII. Idiotype and molecular specificity of human rheumatoid factors: Analysis of cross-reactive idiotype of rheumatoid factor paraproteins from the Wa idiotype groups in relation to their IgG subclass specificity. Scand J Immunol 1988;28:233-240.
38. Suciu-Foca N, Reed E, Rohowsky C, Kung P, King DW: Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA 1983;80:830-834.
39. Zouali M, Eyquem A: Idiotypic-anti-idiotypic interactions in systemic lupus erythematosus: Demonstration of oscillary levels of anti-DNA autoantibodies and reciprocal anti-idiotypic activity in a single patient. Ann Immunol (Inst Pasteur) 1983;134C:377-382.
40. Rossi F, Dietrich G, Kazatchkine MD: Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses. Immunol Rev 1989;110:135-149.
41. Rossi F, Guilbert B, Tonnelle C, Ternynck T, Fumoux F, Avrameas S, Kazatchkine MD: Idiotypic interactions between normal human poly-spccific IgG and natural IgM antibodies. Eur J Immunol 1990;20:2089-2094.
42. 2 antibody recognizes a conformation IgG1 hinge region epitope. J Immunol 1995;154: 6446-6452.
43. 2 autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope. J Immunol 1996;157:4251-4257.
44. Burton DR: Immunoglobulin G: Functional sites. Mol Immunol 1985;22:161-206.
45. Kessler H, Mronga S, Müller G, Moroder L, Huber R: Conformational analysis of an IgG1 hinge peptide derivative in solution determined by NMR spectroscopy and refined by restrained molecular dynamics simulation. Biopolymers 1991;31:1189-1204.
46. Moroder L, Bali JP, Kobayashi Y: Synthetic immunogens. IV Conformational studies on gastrin conjugates with the human immunoglobulin G1 hinge peptide. Biopolymers 1991;31: 595-604.
47. Möller G: Effects of anti-immunoglobulin sera on B lymphocyte function. Immunol Rev 1980; 52:3-231.
48. Cooper MD, Kearney JF, Gathings WE, Lawton AR: Effects of anti-Ig antibodies on the development and differentiation of B cells. Immunol Rev 1980;52:29-53.
49. 2 activity. Transplantation 1992;54:632-635.
50. 2 antibodies with higher kidney transplant survival rates. Transplantation 1982;33:603-605.
51. Süsal C, Maier H, Lorenz K, Opelz G: Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer. Int J Cancer 1994;57:47-50.
52. Süsal C, Daniel V, Oberg HH, Terness P, Huth-Kühne A, Zimmerman R, Opelz G: Striking inverse association of IgG-anti-Fab antibodies and CD4 cell counts in patients with AIDS/ARC. Blood 1992;79:954-957.
53. Sölder B, Marschang P, Wachter H, Dierich MP, Nayyar S, Lewin IV, Stanworth DR: Anti-viral antibodies in HIV infection possess auto-antibody activity against a CHI domain determinant in human IgG: Possible immunological consequences. Immunol Lett 1989;23:9-19.
54. 2 antibodies and possible immunologic control mechanisms in systemic lupus crythematosus. Arthritis Rheum 1984;27:1387-1596.
55. 2 and autoantibody production in patients with cold agglutination. Blood 1995;85:548-551.
56. Terness P, Kirschfink M, Navolan D, Moroder L, Siedler F, Drugarin D, Schneider F, Dufter Ch, Kohl I, Welschof M, Opelz G, Roelcke D: Inverse correlation between IgG-anti-hinge region and antierythrocyte autoantibody in chronic benign and malignant cold agglutination. J Clin Immunol 1997;17:220-227.
57. Silberstein LE: Natural and pathologic human autoimmune responses to carbohydrate antigens on red blood cells. Springer Semin Immunopathol 1993;15:139-153.
58. 2 antibody and escape from suppression by tumor transformation. A model relevant for the pathogenesis of autoimmune hemolytic anemia. Clin Exp Immunol 1993;93:253-258.
59. Terness P, Opelz G: Regulation of antibody response by an IgG-anti-Ig autoantibody occurring during alloimmunization. I. A few IgG molecules inactivate one B cell. Transplantation 1992;54:88-91.
60. Terness P, Berteli AJ, Süsal C, Opelz G: Regulation of antibody response by an IgG-anti-Ig autoantibody occurring during alloimmunization. II. Selective inactivation of antigen receptor-occupied B cells. Transplantation 1992;54:92-96.
61. 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression. Immunology 1973;24:289-301.
62. Sinclair NR StC, Panuskaltsis A: B cell regulation through Fc receptor-mediated signals. Contrib Microbiol Immunol. Basel, Karger, 1989, vol 11, pp 96-123.
63. Phillips N, Parker DC: Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol 1984;132: 627-632.
64. Bijsterbosch MK, Klaus GGB: Cross-linking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via antigen receptors. J Exp Med 1985;162:1825-1836.
65. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV: A 13-amino-acid motif in the cytoplasmatic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 1994;368:70-73.
66. Diegel ML, Rankin BM, Bolen JB, Dubois PM, Kiener PA: Cross-linking of Fc gamma receptor to surface immunoglobulin on B cells provides an inhibitory signal that closes the plasma membrane calcium channel. J Biol Chem 1994; 269:11409-11416.
67. Amigorena S, Bonnerot C, Drake JR, Choquet D, Hunziker W, Guillet JG, Webster P, Sautes C, Mellman I, Fridman WH: Cytoplasmatic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 1992;256: 1808-1812.
68. Ashman RF, Peckham D, Stunz LL: Fc receptor off-signal in the B cell involves apoptosis. J Immunol 1996;157:5-11.
69. Racila E, Hsueh R, Marches R, Tucker TF, Krammer PH, Scheuermann RH, Uhr J: Tumor dormancy and cell signaling: Anti-mu-induced apoptosis in human B-lymphoma cells is not caused by APO-1-APO-1 ligand interaction. Proc Natl Acad Sci USA 1996;93:2165-2168.
70. MacDonald I, Wang H, Grand R, Armitage RJ, Fanslow WC, Gregory CD, Gordon J: Transforming growth factor-beta-1 cooperates with anti-immunoglobulin for induction of apoptosis in group 1 (biopsy-like) Burkitt lymphoma cell lines. Blood 1996;87:1147-1154.
71. Racila E, Scheuermann RH, Picker LJ, Yefenov E, Tucker T, Chang W, Marches R, Street NE, Vitetta ES, Uhr J: Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of B cell lymphoma in SCID mice. J Exp Med 1995;181:1539-1550.
72. 2 autoantibody. Proc Natl Acad Sci USA 1997;94:1902-1907.
73. Fazekas G, Rajnavölgyi E, Kurucz I, Sintar E, Kiss K, Laszlo G, Gergely J: Isolation and characterization of IgG2a-reactive autoantibodies from influenza virus-infected BALB/c mice. Eur J Immunol 1990;20:2719-2729.
74. Borretzen M, Randen I, Zdarsky E, Forre O, Natvig JB, Thompson KM: Control of autoantibody affinity by selection against amino acid replacements in the complementary-determining regions. Proc Natl Acad Sci USA 1994;91: 12917-12921.
75. Thompson KM, Borretzen M, Randen I, Forre O, Natvig JB: V-gene repertoire and hypermutation of rheumatoid factors produced in rheumatoid synovial inflammation and immunized healthy donors. Ann NY Acad Sci 1995;764; 440-449.
76. Mageed RA, Borretzen M, Moyes SP, Thompson KM, Natvig JB: Rheumatoid factor autoantibodies in health and disease. Ann NY Acad Sci 1997;815:296-311.
77. Borretzen M, Chapman C, Natvig JB, Thompson KM: Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage. Eur J Immunol 1997;27: 735-741.
78. Gause A, Gundlach K, Zdichavsky M, Jacobs G, Koch B, Hopf T, Pfreundschuh M: The B lymphocyte in rheumatoid arthritis: Analysis of rearranged V kappa genes from B cells infiltrating the synovial membrane. Eur J Immunol 1995;25:2775-2782.
79. Lee SK, Bridges SL, Koopman WJ, Schroeder HW: The immunoglobulin kappa light chain repertoire expressed in the synovium of a patient with rheumatoid arthritis. Arthritis Rheum 1992;35:905-913.
80. Isakson PC, D'Angelo D, Schetz J, Tardelli L, Pure E: Anti-Ig-stimulated B lymphoblasts can be restimulated via their surface Ig. J Immunol 1989;143:3901-3908.
81. Radovich J, Talmage DW: Antigenic competition: Cellular or humoral. Science 1967;158: 512-515.
82. Lenhard V, Renner D, Hansen B, Opelz G: Suppression of antibody response and prolongation of skin graft survival by multiple blood transfusions in the rat. Transplantation 1985;39: 424-429.
83. Van Snick JL, van Roost E, Marcowitz B, Cambiaso CL, Masson PL: Enhancement of IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes. Eur J Immunol 1978;8:279-285.
84. Clarkson AB, Mellow GH: Rheumatoid factor-like immunoglobulin M protects previously uninfected rat dams and pups from Trypanosoma lewsi. Science 1981;214:186-188.
85. Rajnavölgyi E, Kurucz I, Fazekas G, Sintar E, Laszlo G, Gergely J: In vivo manipulation of IgG2a production by isotype-specific autoantibodies. Mol Immunol 1990;27:1241-1248.
86. Roosnek E, Lanzavecchia A: Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 1991;173:487-489.